These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 12939342)

  • 1. The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis.
    Novack DV; Yin L; Hagen-Stapleton A; Schreiber RD; Goeddel DV; Ross FP; Teitelbaum SL
    J Exp Med; 2003 Sep; 198(5):771-81. PubMed ID: 12939342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Processing of the NF-kappa B2 precursor p100 to p52 is critical for RANKL-induced osteoclast differentiation.
    Maruyama T; Fukushima H; Nakao K; Shin M; Yasuda H; Weih F; Doi T; Aoki K; Alles N; Ohya K; Hosokawa R; Jimi E
    J Bone Miner Res; 2010 May; 25(5):1058-67. PubMed ID: 19874202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activin A stimulates IkappaB-alpha/NFkappaB and RANK expression for osteoclast differentiation, but not AKT survival pathway in osteoclast precursors.
    Sugatani T; Alvarez UM; Hruska KA
    J Cell Biochem; 2003 Sep; 90(1):59-67. PubMed ID: 12938156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pivotal role of the alternative NF-kappaB pathway in maintenance of basal bone homeostasis and osteoclastogenesis.
    Soysa NS; Alles N; Weih D; Lovas A; Mian AH; Shimokawa H; Yasuda H; Weih F; Jimi E; Ohya K; Aoki K
    J Bone Miner Res; 2010 Apr; 25(4):809-18. PubMed ID: 19839765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis.
    Bharti AC; Takada Y; Aggarwal BB
    J Immunol; 2004 May; 172(10):5940-7. PubMed ID: 15128775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RelB-induced expression of Cot, an MAP3K family member, rescues RANKL-induced osteoclastogenesis in alymphoplasia mice by promoting NF-κB2 processing by IKKα.
    Taniguchi R; Fukushima H; Osawa K; Maruyama T; Yasuda H; Weih F; Doi T; Maki K; Jimi E
    J Biol Chem; 2014 Mar; 289(11):7349-61. PubMed ID: 24488495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase alpha.
    Chaisson ML; Branstetter DG; Derry JM; Armstrong AP; Tometsko ME; Takeda K; Akira S; Dougall WC
    J Biol Chem; 2004 Dec; 279(52):54841-8. PubMed ID: 15485831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40 ligation of rheumatoid synovial fibroblasts regulates RANKL-mediated osteoclastogenesis: evidence of NF-kappaB-dependent, CD40-mediated bone destruction in rheumatoid arthritis.
    Lee HY; Jeon HS; Song EK; Han MK; Park SI; Lee SI; Yun HJ; Kim JR; Kim JS; Lee YC; Kim SI; Kim HR; Choi JY; Kang I; Kim HY; Yoo WH
    Arthritis Rheum; 2006 Jun; 54(6):1747-58. PubMed ID: 16736517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40 regulates the processing of NF-kappaB2 p100 to p52.
    Coope HJ; Atkinson PG; Huhse B; Belich M; Janzen J; Holman MJ; Klaus GG; Johnston LH; Ley SC
    EMBO J; 2002 Oct; 21(20):5375-85. PubMed ID: 12374738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism.
    Yao Z; Xing L; Boyce BF
    J Clin Invest; 2009 Oct; 119(10):3024-34. PubMed ID: 19770515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective nuclear factor-κB-inducing kinase in aly/aly mice prevents bone resorption induced by local injection of lipopolysaccharide.
    Soysa NS; Alles N; Takahashi M; Aoki K; Ohya K
    J Periodontal Res; 2011 Apr; 46(2):280-4. PubMed ID: 21348872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoclast differentiation by RANKL requires NF-kappaB-mediated downregulation of cyclin-dependent kinase 6 (Cdk6).
    Ogasawara T; Katagiri M; Yamamoto A; Hoshi K; Takato T; Nakamura K; Tanaka S; Okayama H; Kawaguchi H
    J Bone Miner Res; 2004 Jul; 19(7):1128-36. PubMed ID: 15176996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of either NF-kappaB p50 or p52 in osteoclast precursors is required for IL-1-induced bone resorption.
    Xing L; Carlson L; Story B; Tai Z; Keng P; Siebenlist U; Boyce BF
    J Bone Miner Res; 2003 Feb; 18(2):260-9. PubMed ID: 12568403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon induces NF-kappa B-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-kappa B activation to promote cell survival.
    Yang CH; Murti A; Pfeffer LM
    J Biol Chem; 2005 Sep; 280(36):31530-6. PubMed ID: 16009713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss.
    Ruocco MG; Maeda S; Park JM; Lawrence T; Hsu LC; Cao Y; Schett G; Wagner EF; Karin M
    J Exp Med; 2005 May; 201(10):1677-87. PubMed ID: 15897281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible involvement of IkappaB kinase 2 and MKK7 in osteoclastogenesis induced by receptor activator of nuclear factor kappaB ligand.
    Yamamoto A; Miyazaki T; Kadono Y; Takayanagi H; Miura T; Nishina H; Katada T; Wakabayashi K; Oda H; Nakamura K; Tanaka S
    J Bone Miner Res; 2002 Apr; 17(4):612-21. PubMed ID: 11918218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation.
    Vaira S; Johnson T; Hirbe AC; Alhawagri M; Anwisye I; Sammut B; O'Neal J; Zou W; Weilbaecher KN; Faccio R; Novack DV
    Proc Natl Acad Sci U S A; 2008 Mar; 105(10):3897-902. PubMed ID: 18322009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF.
    Yilmaz ZB; Weih DS; Sivakumar V; Weih F
    EMBO J; 2003 Jan; 22(1):121-30. PubMed ID: 12505990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts.
    Wu X; Pan G; McKenna MA; Zayzafoon M; Xiong WC; McDonald JM
    J Bone Miner Res; 2005 Jan; 20(1):107-16. PubMed ID: 15619676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
    J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.